Dr. Hammers on the Future of Immunotherapy in RCC – OncLive
Dr. Hammers on the Future of Immunotherapy in RCCOncLiveHans Hammers, MD, PhD, associate professor, Internal Medicine, UT Southwestern Medical Center, discusses the future of immunotherapy for patients with renal cell carcinoma (RCC). For patients with… Continue reading
